299 related articles for article (PubMed ID: 34051735)
1. Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.
Liu Z; Zhang W; Cheng X; Wang H; Bian L; Wang J; Han Z; Wang Y; Lian X; Liu B; Ren Z; Zhang B; Jiang Z; Lin Z; Gao Y
Mol Med; 2021 May; 27(1):52. PubMed ID: 34051735
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.
Sun Y; Tian Y; Wang GZ; Zhao SH; Han B; Li YL; Jiang CL
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273854
[TBL] [Abstract][Full Text] [Related]
3. Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells.
Liu Z; Wang H; Jia Y; Wang J; Wang Y; Bian L; Liu B; Lian X; Zhang B; Ren Z; Zhang W; Dai W; Gao Y
Cancer Med; 2021 Aug; 10(15):5218-5234. PubMed ID: 34264013
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients.
Liu B; Liu Z; Wang Y; Lian X; Han Z; Cheng X; Zhu Y; Liu R; Zhao Y; Gao Y
Mol Med; 2021 Sep; 27(1):117. PubMed ID: 34556022
[TBL] [Abstract][Full Text] [Related]
5. Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
Liu Z; Shen F; Wang H; Li A; Wang J; Du L; Liu B; Zhang B; Lian X; Pang B; Liu L; Gao Y
Cell Cycle; 2020 Jul; 19(13):1632-1640. PubMed ID: 32436804
[TBL] [Abstract][Full Text] [Related]
6.
Zhu L; Zheng Y; Hu R; Hu C
Biomed Res Int; 2021; 2021():5486131. PubMed ID: 34631884
[TBL] [Abstract][Full Text] [Related]
7. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
8.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
9. ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.
Xu H; Zhang A; Han X; Li Y; Zhang Z; Song L; Wang W; Lou M
Cancer Immunol Immunother; 2022 Mar; 71(3):645-660. PubMed ID: 34313821
[TBL] [Abstract][Full Text] [Related]
10. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
11. TGIF1 overexpression promotes glioma progression and worsens patient prognosis.
Wang B; Ma Q; Wang X; Guo K; Liu Z; Li G
Cancer Med; 2022 Dec; 11(24):5113-5128. PubMed ID: 35569122
[TBL] [Abstract][Full Text] [Related]
12. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas.
Liu X; Li Y; Sun Z; Li S; Wang K; Fan X; Liu Y; Wang L; Wang Y; Jiang T
Cancer Med; 2018 Sep; 7(9):4273-4283. PubMed ID: 30117304
[TBL] [Abstract][Full Text] [Related]
14. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
15.
Liu Z; Ren Z; Zhang C; Qian R; Wang H; Wang J; Zhang W; Liu B; Lian X; Wang Y; Guo Y; Gao Y
Front Oncol; 2021; 11():608748. PubMed ID: 34976781
[TBL] [Abstract][Full Text] [Related]
16. Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas.
Yang Y; Chen X; Sun J; Chen S; Yang C; Ma Q; Yang J
Sci Rep; 2021 Sep; 11(1):19493. PubMed ID: 34593910
[TBL] [Abstract][Full Text] [Related]
17. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
Yang G; Tang S; Zhang J; Qin L
World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L
Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis.
Zhao C; Zhang N; Cui X; Zhang X; Ren Y; Su C; He J; Zhang W; Sun X; Yang J; Gao X
Cancer Med; 2021 Apr; 10(8):2826-2839. PubMed ID: 33713047
[TBL] [Abstract][Full Text] [Related]
20. Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.
Wang H; Zhao Y; Zhang C; Li M; Jiang C; Li Y
PLoS One; 2014; 9(2):e89782. PubMed ID: 24587032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
